In the UK, we serve pharmaceutical and biotech companies and most of the NHS Trusts, being firmly centered between healthcare and life sciences. What differentiates us is institutional knowledge, gained from being the UK’s leading clinical trial provider through partnerships with the NHS in four ‘prime sites’ covering a population of around 20 million people, and from our more than 270 real world evidence experts. Our advanced technology platforms and capabilities allow us to provide real-time access to operations critical information for our customers. We have unparalleled data. And finally, advanced analytics that underpin faster more precise decision-making, giving actionable insights into patient care and medicines usage, all while preserving patient privacy.
We support UK life sciences from molecule to market across 8 areas:
Q2 Solutions’ central lab based in Livingston helps our customers improve human health through innovation that transforms science and data into actionable medical insights.
Through IQVIA’s CORE-powered Clinical Development and close partnerships with the NHS and research institutions, our clinical operations team ensure the effective delivery of regulatory, start up and clinical monitoring services.
Our team help customers demonstrate how patients can be treated safely, effectively and economically, in the real world setting. We provide the full spectrum of the best-in-class solutions for real-world and late phase evidence development across the global healthcare ecosystem.
Our team is committed to support the NHS hospital for them to drive efficiencies, reduce cost and clinical variation and improve patient outcomes.
We provide solutions to more than 75 percent of NHS hospitals. Working closely with them, we’ve developed tailored solutions to:
As a trusted adviser and partner of choice to suppliers and customers, we secure access to data, providing unique, valuable, innovative solutions and real-world insights, whilst protecting individual patient privacy.
Our team solve healthcare customers’ commercial challenges by delivering innovative solutions through information and service platforms.
We enable healthcare customers to execute their commercialisation plans with speed, flexibility and risk mitigation. We design and deliver innovative customer engagement.
We enable every interaction with health care professionals to be planned, delivered and measured in an orchestrated way.
Through our strategic collaborations and initiatives with UK’s healthcare stakeholders, we are committed to a better prevention, earlier diagnosis and more targeted treatment for patients in the UK and across the world.
IQVIA's collaboration with Genomics England to co-develop the platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients is a critical step in advancing genomic research. This alliance will enable faster and more efficient drug research, more robust evidence to support treatment value, and greater access to personalized medicines; whilst protecting patient privacy.
IQVIA has taken a leading role in addressing data access challenges by partnering in the development and validation of the Simulacrum. The Simulacrum is a simulated oncology dataset structured to model properties of the data collected within the Cancer Analysis System (CAS), but which contains no actual patient data. IQVIA has formulated the Oncology Insights Simulator, which uses the Simulacrum to conduct real world studies leveraging one of the largest and most detailed population-based cancer databases in the world. Through this innovative approach, IQVIA can perform clinically relevant and statistically precise studies that answer critical questions about cancer patients and their treatments without compromising patient confidentiality.
In collaboration with EMIS Health, IQVIA launched the EMIS App Library by AppScript, enabling more than half of GP surgeons in England to to recommend apps to millions of patients.
By fully appreciating and leveraging clinicians’ real world activity, we accomplish our vision of Human Data Science, where every clinical decision can be made based on credible and robust evidence. This technology has the potential to drive significant cost savings for the NHS through improved prevention and management of chronic conditions and support the delivery of clinical research goals as set out in the NHS Long Term Plan, contributing to make the NHS the world’s most advanced primary healthcare system with respect to the delivery of digitally enabled care.
Driven by passion for a healthier world, our teams continue to innovate and develop new solutions to advance healthcare. Below are a few examples of projects where boundaries were pushed and health outcomes improved.
Better clinical trials:
Further patient engagement:
Information and figures correct as of 15 July 2019.